-
integrationacademy.ahrq.gov/about/academy-team/niac-bios
June 01, 2022 - BHI Ecosystem
Products
Playbooks
Medications for Opioid … AHRQ Initiatives
EvidenceNOW: Managing Unhealthy Alcohol Use
Opioid … Initiative
Older Adult Opioid Initiative
Other HHS Initiatives … He is also a member of Maine’s Opioid Clinical Advisory Group and Maine’s Governor has appointed him
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/CDS%20Connect%20Pilot%20Site%20Training%20Plan_Final_0.docx
July 23, 2024 - background on the CDS Connect project
· Pilot objectives
· Current evidence-based guidance related to opioid
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
October 08, 2025 - Race, Other % Pain Duration Measure
(Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid … Previous treatment with weak opioid: 42 vs. 38
Previous treatment with strong opioid: 19 vs. 11 96 71 … : 4% (7/167) vs. 4% (7/172)
Other opioid: 20% (33/167) vs. 18% (31/172) 339 339 THC 2.7 mg/CBD 2.5 mg … : 9 vs. 13
Opioid: 2 vs. 3
Strong opioid: 3 vs. 0 66 66 THC 2.7 mg/CBD 2.5 mg per 100 mcl oromucosal … Use (Mean Daily Dose [MDD]) Opioid Equivalents Assessment Time (Weeks) Variance Type for Opioid Use
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
January 01, 2022 - Race, Other % Pain Duration Measure
(Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid … Previous treatment with weak opioid: 42 vs. 38
Previous treatment with strong opioid: 19 vs. 11 96 71 … : 4% (7/167) vs. 4% (7/172)
Other opioid: 20% (33/167) vs. 18% (31/172) 339 339 THC 2.7 mg/CBD 2.5 mg … : 9 vs. 13
Opioid: 2 vs. 3
Strong opioid: 3 vs. 0 66 66 THC 2.7 mg/CBD 2.5 mg per 100 mcl oromucosal … Use (Mean Daily Dose [MDD]) Opioid Equivalents Assessment Time (Weeks) Variance Type for Opioid Use
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
January 01, 2022 - Race, Other % Pain Duration Measure
(Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid … Previous treatment with weak opioid: 42 vs. 38
Previous treatment with strong opioid: 19 vs. 11 96 71 … : 4% (7/167) vs. 4% (7/172)
Other opioid: 20% (33/167) vs. 18% (31/172) 339 339 THC 2.7 mg/CBD 2.5 mg … : 9 vs. 13
Opioid: 2 vs. 3
Strong opioid: 3 vs. 0 66 66 THC 2.7 mg/CBD 2.5 mg per 100 mcl oromucosal … Use (Mean Daily Dose [MDD]) Opioid Equivalents Assessment Time (Weeks) Variance Type for Opioid Use
-
hcup-us.ahrq.gov/overview.jsp
February 01, 2022 - to compare national or State statistics on a range of healthcare topics, such as trends by payer and opioid-related
-
integrationacademy.ahrq.gov/sites/default/files/2022-11/AcademyProjectSummary-11-22-2022.pdf
January 01, 2022 - behavioral healthcare and primary care, including,
but not limited to substance use disorder (SUD), such as opioid
-
psnet.ahrq.gov/issue/rapid-response-team-implementation-and-hospital-mortality
December 03, 2014 - March 21, 2018
Chronic pain diagnoses and opioid dispensings among insured individuals
-
psnet.ahrq.gov/issue/best-practices-chemotherapy-administration-pediatric-oncology-quality-and-safety-process
September 23, 2020 - September 23, 2020
Prescription opioid dose reductions and potential adverse events:
-
psnet.ahrq.gov/issue/impact-pharmacist-led-interventions-medication-related-problems-among-patients-treated-cancer
May 10, 2017 - April 24, 2024
A health system–wide initiative to decrease opioid-related morbidity and
-
psnet.ahrq.gov/issue/prospective-observational-study-physician-handoff-intensive-care-unit-ward-patient-transfers
October 08, 2013 - November 18, 2016
Opioid prescribing patterns and complications in the dermatology Medicare
-
psnet.ahrq.gov/issue/do-hospitals-provide-lower-quality-care-weekends
January 12, 2022 - March 14, 2018
Patient outcomes in dose reduction or discontinuation of long-term opioid
-
psnet.ahrq.gov/issue/speaking-same-language-international-variations-safety-information-accompanying-top-selling
September 25, 2008 - More
Related Resources
Patient Safety Primers
Opioid
-
psnet.ahrq.gov/issue/increased-patient-safety-related-incidents-following-transition-daylight-savings-time
May 19, 2021 - Download Citation
Related Resources From the Same Author(s)
Influence of opioid
-
psnet.ahrq.gov/issue/reducing-automated-dispensing-cabinet-overrides-peri-anesthesia-care-unit-quality-improvement
June 07, 2023 - WebM&M Cases
Fatal Patient-Controlled Analgesia (PCA) Opioid-Induced
-
psnet.ahrq.gov/issue/developing-agreement-never-events-primary-care-dentistry-international-edelphi-study
October 05, 2016 - December 16, 2020
A mixed-methods analysis of patient safety incidents involving opioid
-
psnet.ahrq.gov/issue/emergency-department-boarding-and-adverse-hospitalization-outcomes-among-patients-admitted
July 13, 2016 - November 3, 2021
Adverse events and emergency department opioid prescriptions in adolescents
-
psnet.ahrq.gov/issue/frequency-and-risk-factors-medication-errors-pharmacists-during-order-verification-tertiary
January 23, 2013 - May 18, 2019
Predictors of in-hospital postoperative opioid overdose after major elective
-
psnet.ahrq.gov/issue/preventing-potential-patient-harm-through-clinical-content-interventions-during-oncology
October 30, 2024 - July 1, 2020
Indication-specific opioid prescribing for US patients with Medicaid or
-
psnet.ahrq.gov/issue/serious-adverse-events-pediatric-procedural-sedation-and-after-implementation-pre-sedation
February 12, 2020 - January 12, 2022
Adverse events and emergency department opioid prescriptions in adolescents